Related Experiment Videos
Modulation of multidrug resistance: at the threshold
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology·2009
A phase I trial of liposomal doxorubicin, paclitaxel and valspodar (PSC-833), an inhibitor of multidrug resistance.
Annals of oncology : official journal of the European Society for Medical Oncology·2005
A phase I trial of doxorubicin, paclitaxel, and valspodar (PSC 833), a modulator of multidrug resistance.
Clinical cancer research : an official journal of the American Association for Cancer Research·2001
Effect of high-dose cyclosporine on etoposide pharmacodynamics in a trial to reverse P-glycoprotein (MDR1 gene) mediated drug resistance.
Cancer chemotherapy and pharmacology·2001
Darolutamide Alone and in Combination With Goserelin in Androgen Receptor-Positive Salivary Gland Carcinoma: Results From the Phase II DISCOVARY Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
High-Risk Smoldering Multiple Myeloma: A Review of Controversies in Early Treatment Versus Observation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Long-Term Clinical Outcomes of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory ALL.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026